TTIC
EXAS

Tower Trust & Investment Company’s Exact Sciences EXAS Stock Holding History

Tower Trust & Investment Company’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-900
Closed -$91.4K – 211
2025
Q4 		$91.4K Hold
900
– – 0.06% 111
2025
Q3 		$49.2K Hold
900
– – 0.03% 119
2025
Q2 		$47.8K Hold
900
– – 0.03% 124
2025
Q1 		$41.1K Buy
+900
New +$45.6K 0.03% 123

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Tower Trust & Investment Company's EXAS Position: Q1 2026 in Review

Tower Trust & Investment Company sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 900 shares — an estimated $91.4K sold.

Tower Trust & Investment Company first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $91.4K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Tower Trust & Investment Company reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Tower Trust & Investment Company sold 900 Exact Sciences shares in Q1 2026, an estimated $91.4K.
  • Tower Trust & Investment Company first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
  • Tower Trust & Investment Company's Exact Sciences position peaked at $91.4K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Tower Trust & Investment Company's 13F filing for Q1 2026, filed 8 Apr 2026.